InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Brazzell Romulus K, Directeur Médical. Officer active across 2 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 15 disclosures have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €115k. Activity tracked since 28 June 2021. The latest transaction was filed on 6 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations15 total
10,100 shares0Common StockSEC:0001415889-25-001061:0
5,489 shares@ US$4.7568.5% of flowCommon StockSEC:0001415889-24-018373:0
2,002 shares@ US$6.0931.5% of flowCommon StockSEC:0001415889-24-015223:0
6,500 shares0Common StockSEC:0001415889-24-000770:0
49,356 shares0Common StockSEC:0001415889-23-010284:0
17,916 sharesCommon StockSEC:0001415889-23-009135:0
12,800 shares0Common StockSEC:0001415889-23-000638:0
261 shares@ US$6.512.1% of flowCommon StockSEC:0001415889-22-010879:0
3,144 shares@ US$0.370.0071% mcap1.4% of flowCommon StockSEC:0001415889-22-007061:0
3,504 shares@ US$1.305.1% of flowCommon StockSEC:0001415889-22-000404
3,504 shares@ US$1.300.026% mcap5.2% of flowCommon StockSEC:0001415889-22-000404:0
12,757 shares@ US$1.800.13% mcap25.3% of flowCommon StockSEC:0001415889-21-005010:0
12,757 shares@ US$1.8024.8% of flowCommon StockSEC:0001415889-21-005010
3,034 shares@ US$5.7718.4% of flowCommon StockSEC:0001415889-21-003258
3,034 shares@ US$5.770.095% mcap18.8% of flowCommon StockSEC:0001415889-21-003258:0
15 of 15 declarations
About Brazzell Romulus K
Romulus K. Brazzell is the Chief Medical Officer at Kala Pharmaceuticals, Inc. He is responsible for the company's medical direction, overseeing clinical and research activities. His expertise is essential for the development of new treatments.
